Related Experiment Videos
Relapsing eosinophilic myositis causing acute muscle compartment syndrome
British Journal of Rheumatology
|May 1, 1993
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Language matters: Guidance for person-centred diabetes communication in Ireland.
Diabetic medicine : a journal of the British Diabetic Association·2026
The development and acceptability of an educational and training intervention for recruiters to neonatal trials: the TRAIN project.
BMC medical research methodology·2023
Low-density lipoprotein cholesterol in adolescents and young adults with type 1 diabetes: Data from the Australasian Diabetes Data Network registry.
Diabetic medicine : a journal of the British Diabetic Association·2023
Cylindrospermopsin impairs tubular transport function in kidney cells LLC-PK1.
Toxicology letters·2021
Introduction of a national program for HbA1c testing in Guyana South America and initial results.
Diabetes research and clinical practice·2019
Hypothyroid myopathy as a complication of interferon alpha therapy for chronic hepatitis C virus infection.
British journal of rheumatology·1999
Benefit of 6 months long-term physical training in polymyositis/dermatomyositis patients.
British journal of rheumatology·1999
Circulating interleukin-16 in systemic lupus erythematosus.
British journal of rheumatology·1999
Antibodies to Klebsiella pneumoniae lipopolysaccharide in patients with ankylosing spondylitis.
British journal of rheumatology·1999
Clinical course and remission rate in patients with early rheumatoid arthritis: relationship to outcome after 5 years.
British journal of rheumatology·1999
A study of the frequency of pericardial and pleural effusions in scleroderma.
British journal of rheumatology·1999
Upadacitinib for refractory generalized lichen sclerosus: a case report and brief literature review.
Frontiers in immunology·2026
Case Report: A case report of bullous pemphigoid triggered by sintilimab (PD-1 inhibitor).
Frontiers in immunology·2026